Drug Type Gene therapy |
Synonyms- |
Target |
Action modulators |
Mechanism CXCL9 modulators(C-X-C motif chemokine ligand 9 modulators), IL-12 modulators(Interleukin-12 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | United States | 22 Jun 2020 |